[120,121,122] These NK cells have shown increased anti-tumor activity against PD-1/PD-L2+ tumor cells and may be relevant to the treatment of tumors showing a T-cell-resistant phenotype. This evidence concerns the gene PDCD1LG2 and neoplasm.